Literature DB >> 19884335

The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype.

Jose Yuste1, Suneeta Khandavilli, Naadir Ansari, Kairya Muttardi, Laura Ismail, C Hyams, Jeffrey Weiser, Timothy Mitchell, Jeremy S Brown.   

Abstract

Streptococcus pneumoniae may evade complement activity by binding of factor H (FH), a negative regulator of the alternative pathway, to the surface protein PspC. However, existing data on the effects of FH binding to PspC on complement activity are conflicting, and there is also considerable allelic variation in PspC structure between S. pneumoniae strains that may influence PspC-dependent effects on complement. We have investigated interactions with complement for several S. pneumoniae strains in which the gene encoding PspC has been deleted. The degree of FH binding varied between strains and was entirely dependent on PspC for seven strains. Data obtained with TIGR4 strains expressing different capsular serotypes suggest that FH binding is affected by capsular serotype. Results of immunoblot analysis for C3 degradation products and iC3b deposition assays suggested that FH bound to PspC retained functional activity, but loss of PspC had strikingly varied effects on C3b/iC3b deposition on S. pneumoniae, with large increases on serotype 4, 6A, 6B, and 9V strains but only small increases or even decreases on serotype 2, 3, 17, and 23F strains. Repeating C3b/iC3b assays with TIGR4 strains expressing different capsular serotypes suggested that differences in the effect of PspC on C3b/iC3b deposition were largely independent of capsular serotype and depend on strain background. However, data obtained from infection in complement-deficient mice demonstrated that differences between strains in the effects of PspC on complement surprisingly did not influence the development of septicemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19884335      PMCID: PMC2798213          DOI: 10.1128/IAI.00541-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice.

Authors:  Lisa R Quin; Quincy C Moore; Larry S McDaniel
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

2.  Interaction of clinical isolates of Streptococcus pneumoniae with human complement factor H.

Authors:  Lisa R Quin; Chinwendu Onwubiko; Stephanie Carmicle; Larry S McDaniel
Journal:  FEMS Microbiol Lett       Date:  2006-11       Impact factor: 2.742

3.  Peritoneal challenge modulates expression of pneumococcal surface protein C during bacteremia in mice.

Authors:  Lisa R Quin; Quincy C Moore; Justin A Thornton; Larry S McDaniel
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

4.  PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation.

Authors:  Jie Li; David T Glover; Alexander J Szalai; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

5.  Pneumococcal virulence gene expression and host cytokine profiles during pathogenesis of invasive disease.

Authors:  Layla K Mahdi; Abiodun D Ogunniyi; Kim S LeMessurier; James C Paton
Journal:  Infect Immun       Date:  2007-11-26       Impact factor: 3.441

6.  Factor H binding to PspC of Streptococcus pneumoniae increases adherence to human cell lines in vitro and enhances invasion of mouse lungs in vivo.

Authors:  Lisa R Quin; Chinwendu Onwubiko; Quincy C Moore; Megumi Fujioka Mills; Larry S McDaniel; Stephanie Carmicle
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

7.  Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.

Authors:  Jose Yuste; Ashwin Sen; Lennart Truedsson; Göran Jönsson; Liang-Seah Tay; Catherine Hyams; Helen E Baxendale; Fiona Goldblatt; Marina Botto; Jeremy S Brown
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

8.  Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H.

Authors:  Abiodun D Ogunniyi; Marcin Grabowicz; Layla K Mahdi; Jan Cook; David L Gordon; Tania A Sadlon; James C Paton
Journal:  FASEB J       Date:  2008-10-29       Impact factor: 5.191

9.  The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells.

Authors:  Sven Hammerschmidt; Vaibhav Agarwal; Anja Kunert; Steffi Haelbich; Christine Skerka; Peter F Zipfel
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

10.  Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae.

Authors:  Jose Yuste; Marina Botto; Stephen E Bottoms; Jeremy S Brown
Journal:  PLoS Pathog       Date:  2007-09-28       Impact factor: 6.823

View more
  30 in total

Review 1.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

2.  Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.

Authors:  Elisa Ramos-Sevillano; Ana Urzainqui; Susana Campuzano; Miriam Moscoso; Fernando González-Camacho; Mirian Domenech; Santiago Rodríguez de Córdoba; Francisco Sánchez-Madrid; Jeremy S Brown; Ernesto García; Jose Yuste
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

3.  Two DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease.

Authors:  L E Cron; K Stol; P Burghout; S van Selm; E R Simonetti; H J Bootsma; P W M Hermans
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

4.  Role of the alternative and classical complement activation pathway in complement mediated killing against Streptococcus pneumoniae colony opacity variants during acute pneumococcal otitis media in mice.

Authors:  Qian Li; Yong Xing Li; Kelsey Douthitt; Gregory L Stahl; Joshua M Thurman; Hua Hua Tong
Journal:  Microbes Infect       Date:  2012-08-30       Impact factor: 2.700

Review 5.  Models of immune selection for multi-locus antigenic diversity of pathogens.

Authors:  Maria Georgieva; Caroline O Buckee; Marc Lipsitch
Journal:  Nat Rev Immunol       Date:  2019-01       Impact factor: 53.106

6.  Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC.

Authors:  Adriana T Moreno; Maria Leonor S Oliveira; Paulo L Ho; Cintia F M Vadesilho; Giovana M P Palma; Jorge M C Ferreira; Daniela M Ferreira; Silvia R Santos; Marina B Martinez; Eliane N Miyaji
Journal:  Clin Vaccine Immunol       Date:  2012-02-15

7.  Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model.

Authors:  Fabio Cafini; Jose Yuste; Maria-Jose Giménez; David Sevillano; Lorenzo Aguilar; Luis Alou; Elisa Ramos-Sevillano; Martha Torrico; Natalia González; Ernesto García; Pilar Coronel; Jose Prieto
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

8.  Streptococcus pneumoniae PspC Subgroup Prevalence in Invasive Disease and Differences in Contribution to Complement Evasion.

Authors:  Erika van der Maten; Bryan van den Broek; Marien I de Jonge; Kim J W Rensen; Marc J Eleveld; Aldert L Zomer; Amelieke J H Cremers; Gerben Ferwerda; Ronald de Groot; Jeroen D Langereis; Michiel van der Flier
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

9.  The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-terminal heparin-binding domain of vitronectin.

Authors:  Sylvia Voss; Teresia Hallström; Malek Saleh; Gerhard Burchhardt; Thomas Pribyl; Birendra Singh; Kristian Riesbeck; Peter F Zipfel; Sven Hammerschmidt
Journal:  J Biol Chem       Date:  2013-04-19       Impact factor: 5.157

10.  Pneumococcal PspA and PspC proteins: potential vaccine candidates for experimental otitis media.

Authors:  Patricia A Schachern; Vladimir Tsuprun; Patricia Ferrieri; David E Briles; Sarah Goetz; Sebahattin Cureoglu; Michael M Paparella; Steven Juhn
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-06-24       Impact factor: 1.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.